Suppr超能文献

美国肝细胞癌风险因素的人群归因分数。

Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.

机构信息

Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany.

出版信息

Am J Gastroenterol. 2013 Aug;108(8):1314-21. doi: 10.1038/ajg.2013.160. Epub 2013 Jun 11.

Abstract

OBJECTIVES

Risk factors for hepatocellular carcinoma (HCC) include hepatitis B and C viruses (HBV, HCV), excessive alcohol consumption, rare genetic disorders and diabetes/obesity. The population attributable fractions (PAF) of these factors, however, have not been investigated in population-based studies in the United States.

METHODS

Persons ≥68 years diagnosed with HCC (n=6,991) between 1994 and 2007 were identified in the SEER-Medicare database. A 5% random sample (n=255,702) of persons residing in SEER locations were selected for comparison. For each risk factor, odds ratios (ORs), 95% confidence intervals (95% CI) and PAFs were calculated.

RESULTS

As anticipated, the risk of HCC was increased in relationship to each factor: HCV (OR 39.89, 95% CI: 36.29-43.84), HBV (OR 11.17, 95% CI: 9.18-13.59), alcohol-related disorders (OR 4.06, 95% CI: 3.82-4.32), rare metabolic disorders (OR 3.45, 95% CI: 2.97-4.02), and diabetes and/or obesity (OR 2.47, 95% CI: 2.34-2.61). The PAF of all factors combined was 64.5% (males 65.6%; females 62.2%). The PAF was highest among Asians (70.1%) and lowest among black persons (52.4%). Among individual factors, diabetes/obesity had the greatest PAF (36.6%), followed by alcohol-related disorders (23.5%), HCV (22.4%), HBV (6.3%) and rare genetic disorders (3.2%). While diabetes/obesity had the greatest PAF among both males (36.4%) and females (36.7%), alcohol-related disorders had the second greatest PAF among males (27.8%) and HCV the second greatest among females (28.1%). Diabetes/obesity had the greatest PAF among whites (38.9%) and Hispanics (38.1%), while HCV had the greatest PAF among Asians (35.4%) and blacks (34.9%). The second greatest PAF was alcohol-related disorders in whites (25.6%), Hispanics (30.1%) and blacks (and 18.5%) and HBV in Asians (28.5%).

CONCLUSIONS

The dominant risk factors for HCC in the United States among persons ≥68 years differ by sex and race/ethnicity. Overall, eliminating diabetes/obesity could reduce the incidence of HCC more than the elimination of any other factor.

摘要

目的

肝细胞癌(HCC)的危险因素包括乙型肝炎和丙型肝炎病毒(HBV、HCV)、过量饮酒、罕见的遗传疾病和糖尿病/肥胖症。然而,在美国基于人群的研究中,这些因素的人群归因分数(PAF)尚未得到调查。

方法

在 SEER-Medicare 数据库中确定了 1994 年至 2007 年间诊断为 HCC(n=6991)的≥68 岁的患者。选择 SEER 地点居住的人群的 5%随机样本(n=255702)进行比较。对于每个危险因素,计算比值比(OR)、95%置信区间(95%CI)和 PAF。

结果

正如预期的那样,每种因素的 HCC 风险都增加:HCV(OR 39.89,95%CI:36.29-43.84)、HBV(OR 11.17,95%CI:9.18-13.59)、酒精相关疾病(OR 4.06,95%CI:3.82-4.32)、罕见代谢疾病(OR 3.45,95%CI:2.97-4.02)和糖尿病和/或肥胖症(OR 2.47,95%CI:2.34-2.61)。所有因素综合的 PAF 为 64.5%(男性 65.6%;女性 62.2%)。亚洲人的 PAF 最高(70.1%),黑人的 PAF 最低(52.4%)。在个别因素中,糖尿病/肥胖症的 PAF 最高(36.6%),其次是酒精相关疾病(23.5%)、HCV(22.4%)、HBV(6.3%)和罕见遗传疾病(3.2%)。虽然糖尿病/肥胖症在男性(36.4%)和女性(36.7%)中的 PAF 最高,但酒精相关疾病在男性中的 PAF 排名第二(27.8%),而 HCV 在女性中的 PAF 排名第二(28.1%)。糖尿病/肥胖症在白人(38.9%)和西班牙裔(38.1%)中的 PAF 最高,而 HCV 在亚洲人(35.4%)和黑人(34.9%)中的 PAF 最高。第二大 PAF 是白人(25.6%)、西班牙裔(30.1%)和黑人(和 18.5%)中的酒精相关疾病以及亚洲人的 HBV(28.5%)。

结论

≥68 岁人群中,美国 HCC 的主要危险因素因性别和种族/民族而异。总体而言,消除糖尿病/肥胖症可能比消除任何其他因素更能降低 HCC 的发病率。

相似文献

1
Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.
Am J Gastroenterol. 2013 Aug;108(8):1314-21. doi: 10.1038/ajg.2013.160. Epub 2013 Jun 11.
2
Population attributable fractions of risk factors for hepatocellular carcinoma in the United States.
Cancer. 2016 Jun 1;122(11):1757-65. doi: 10.1002/cncr.29971. Epub 2016 Mar 21.
3
The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
Am J Gastroenterol. 2001 Aug;96(8):2462-7. doi: 10.1111/j.1572-0241.2001.04054.x.
5
The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma.
Ann Oncol. 2009 Feb;20(2):353-7. doi: 10.1093/annonc/mdn565. Epub 2008 Aug 22.
9
Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
Gastroenterology. 2004 Nov;127(5 Suppl 1):S35-50. doi: 10.1053/j.gastro.2004.09.014.

引用本文的文献

1
Mitochondrial dysfunction in hepatocellular carcinoma: from metabolism to targeted therapies.
Mol Cell Biochem. 2025 Aug 30. doi: 10.1007/s11010-025-05377-x.
2
Targeted degradation of GSPT1 and NEK7 by a molecular glue prodrug for treatment of HCC.
Commun Chem. 2025 Aug 14;8(1):247. doi: 10.1038/s42004-025-01641-9.
3
Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies.
J Can Assoc Gastroenterol. 2024 Aug 9;7(5):331-345. doi: 10.1093/jcag/gwae025. eCollection 2024 Oct.
6
Liver Cancer Etiology in Asian Subgroups and American Indian, Black, Latino, and White Populations.
JAMA Netw Open. 2025 Mar 3;8(3):e252208. doi: 10.1001/jamanetworkopen.2025.2208.
7
Pan-serological antibodies and liver cancer risk: a nested case-control analysis.
Sci Rep. 2025 Feb 14;15(1):5450. doi: 10.1038/s41598-025-89629-2.
9
Risk of Malignancy in Indeterminate Liver Nodules Among Patients with Cirrhosis: A Retrospective Cohort Study.
J Gastrointest Cancer. 2024 Oct 16;56(1):1. doi: 10.1007/s12029-024-01122-7.
10
Prospective cohort for early detection of liver cancer (Pearl): a study protocol.
BMJ Open. 2024 Oct 1;14(10):e085541. doi: 10.1136/bmjopen-2024-085541.

本文引用的文献

2
Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study.
J Natl Cancer Inst. 2011 Nov 16;103(22):1686-95. doi: 10.1093/jnci/djr395. Epub 2011 Oct 21.
3
Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic?
Hepatol Res. 2012 Jan;42(1):1-14. doi: 10.1111/j.1872-034X.2011.00872.x. Epub 2011 Sep 15.
4
The global epidemiology of hepatocellular carcinoma: present and future.
Clin Liver Dis. 2011 May;15(2):223-43, vii-x. doi: 10.1016/j.cld.2011.03.006.
8
Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.
Clin Gastroenterol Hepatol. 2011 May;9(5):428-33; quiz e50. doi: 10.1016/j.cgh.2011.01.023. Epub 2011 Feb 12.
9
Ethnicity and health disparities in alcohol research.
Alcohol Res Health. 2010;33(1-2):152-60.
10
Autoimmune hepatitis, cirrhosis, and hepatocellular carcinoma (HCC).
Dig Dis Sci. 2011 Feb;56(2):276-8. doi: 10.1007/s10620-010-1476-y.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验